Three AOA2-related SETX mutations, Q868X, R1363X, and P413L have been reported in Uterine Carcinoma, colon carcinoma and skin melanoma, respectively, suggesting that loss of SETX function might be beneficial for tumor development and progression (Fig. 4B). The gene discussed is SETX; the disease is cutaneous melanoma.